Prasidh Chhabria drives AI-powered transformation for healthcare organizations at Percepta, a General Catalyst (GC) subsidiary recently emerged from stealth. At Percepta, Prasidh is responsible for shaping and deploying the industry’s most ambitious AI playbook, working with customers and leadership across the GC ecosystem to design, build, and operationalize large-scale AI products that fundamentally reimagine health and care.
Prior to Percepta, Prasidh was a Senior Product Manager at Aetion (acquired by Datavant), where he led the core Evidence Platform enabling rigorous causal inference on real-world patient data. Building AI/ML capabilities from scratch, including patient risk prediction models trained on 400M+ patient records and LLM-powered tools to translate scientific intent into robust evidence, he doubled product portfolio and commercial pipeline leading up to the acquisition by Datavant. Earlier, Prasidh served at McKinsey & Company, advising healthcare, biopharma, and technology clients on product strategy, advanced analytics, and ML-led optimization.
Prasidh holds an A.B. and S.M. in Applied Mathematics summa cum laude from Harvard University, where he published research in causal reinforcement learning for mobile health interventions in leading academic venues. Raised across the US and India, he cares deeply about advancing accessible, cutting-edge precision healthcare innovation globally. Prasidh lives in New York City.
